ATE357241T1 - Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin - Google Patents

Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin

Info

Publication number: ATE357241T1
Authority: AT; Austria
Prior art keywords: chronic wounds; leucine; treating; composition containing; dietary composition
Prior art date: 2003-05-22

Application number

AT04748592T

Other languages

English (en)

Inventor

Wendeline Wouters-Wesseling

Lisette Wilhelmina Wagenaar

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-22

Filing date

2004-05-19

Publication date

2007-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33462161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357241(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-05-19 Application filed by Nutricia Nv filed Critical Nutricia Nv

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE357241T1 publication Critical patent/ATE357241T1/de

Links

DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title abstract 4
206010052428 Wound Diseases 0.000 title abstract 3
208000027418 Wounds and injury Diseases 0.000 title abstract 3
230000001684 chronic effect Effects 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000004471 Glycine Substances 0.000 title abstract 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 title abstract 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 title abstract 2
235000007882 dietary composition Nutrition 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
230000002265 prevention Effects 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
150000001720 carbohydrates Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Inorganic Chemistry (AREA)
Pediatric Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

AT04748592T 2003-05-22 2004-05-19 Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin ATE357241T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03076556		2003-05-22

Publications (1)

Publication Number	Publication Date
ATE357241T1 true ATE357241T1 (de)	2007-04-15

Family

ID=33462161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04748592T ATE357241T1 (de)	2003-05-22	2004-05-19	Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin

Country Status (11)

Country	Link
US (1)	US20070042019A1 (de)
EP (1)	EP1633377B1 (de)
JP (1)	JP2007500208A (de)
CN (1)	CN100448453C (de)
AT (1)	ATE357241T1 (de)
AU (1)	AU2004241884B2 (de)
BR (1)	BRPI0410761A (de)
CA (1)	CA2526349A1 (de)
DE (1)	DE602004005455T2 (de)
ES (1)	ES2282880T3 (de)
WO (1)	WO2004103383A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102160650B (zh) *	2004-01-14	2012-12-26	味之素株式会社	含甘氨酸食品及其应用
MX2008009574A (es)	2006-02-01	2008-09-04	Nestec Sa	Sistema y metodos nutricionales para aumentar la longevidad.
CA2664139C (en) *	2006-10-19	2013-08-13	Nestec S.A.	Nutritional product for long-term feeding of elderly
MX2009003778A (es) *	2006-10-19	2009-04-22	Nestec Sa	Alimentacion a largo plazo para paciente de cancer.
JP5221094B2 (ja) *	2007-09-28	2013-06-26	テルモ株式会社	褥瘡患部の皮下筋層の再生剤
BR112012012476A2 (pt) *	2009-11-25	2015-09-15	Nestec Sa	"composições nutritivas incluindo um componente de alta proteína e nucleotídeos exôgenos"
US9486003B2 (en)	2010-06-28	2016-11-08	Nestec S.A.	Hypocaloric, high protein nutritional compositions and methods of using same
CN103431277B (zh) *	2013-08-31	2014-08-27	山东卫康生物医药科技有限公司	一种供创伤、手术患者食用的五谷杂粮全营养配方食品
ITMI20131660A1 (it)	2013-10-08	2015-04-09	Professional Dietetics Srl	Uso di una combinazione per la prevenzione delle mucositi indotte da radiazioni o da chemioterapici
EP3541205B1 (de) *	2016-11-16	2024-05-22	Fresenius Kabi Deutschland GmbH	Ernährungsmässig vollständige flüssige zusammensetzungen zur verwendung in der therapie von unterernährung im zusammenhang mit chronisch obstruktiver lungenerkrankung, neurologischen erkrankungen oder störungen und/oder wunden, die kollagenhydrolysat enthalten
DE102018124227A1 (de)	2018-10-01	2020-04-02	sanaFactur GmbH	Zubereitung zur Verbesserung körpereigener Wundheilung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4025650A (en) *	1975-11-24	1977-05-24	Control Drug, Inc.	Method and composition for preventing nutritional deficiency
US4112123A (en) *	1976-07-21	1978-09-05	Beatrice Foods Co.	Nutritionally balanced single food composition and method of production
US4780475A (en) *	1986-02-03	1988-10-25	Cerra Frank B	Preparation for the prevention of catabolism
US5576351A (en) *	1989-12-29	1996-11-19	Mcgaw, Inc.	Use of arginine as an immunostimulator
US5714472A (en) *	1993-12-23	1998-02-03	Nestec Ltd.	Enternal formulation designed for optimized nutrient absorption and wound healing
US5719133A (en) *	1994-09-21	1998-02-17	Novartis Nutrition Ag	Adolescent dietary composition
JP4011638B2 (ja) *	1994-12-27	2007-11-21	イーエヌ大塚製薬株式会社	経口経腸栄養組成物
US5656608B1 (en) *	1995-02-23	2000-09-26	Novartis Nutrition Ltd	Amino acid compositions and methods of treatment using same
US5733884A (en) *	1995-11-07	1998-03-31	Nestec Ltd.	Enteral formulation designed for optimized wound healing
US5922766A (en) *	1997-07-02	1999-07-13	Acosta; Phyllis J. B.	Palatable elemental medical food
JPH11130669A (ja) *	1997-10-28	1999-05-18	Ajinomoto Co Inc	褥瘡予防治療用アミノ酸栄養剤
ID24710A (id) *	1998-05-12	2000-08-03	Nutricia Nv	Komposisi nutrisi untuk perawatan luka karena tekanan
CN1126541C (zh) *	1999-12-03	2003-11-05	中国人民解放军军事医学科学院放射医学研究所	新型复合氨基酸组合物
IL152004A (en) *	2000-04-18	2005-11-20	Nestle Sa	Process for preparing enteral formulations using nutritional modules and nutritional modules for usetherein
DE20101225U1 (de) *	2001-01-24	2001-06-13	Sportmedizin Team Vertriebs Gmbh, Berneck	Präparat für hohe körperliche Beanspruchung

2004
- 2004-05-19 AU AU2004241884A patent/AU2004241884B2/en not_active Ceased
- 2004-05-19 CA CA002526349A patent/CA2526349A1/en not_active Abandoned
- 2004-05-19 CN CNB2004800175072A patent/CN100448453C/zh not_active Expired - Lifetime
- 2004-05-19 US US10/557,495 patent/US20070042019A1/en not_active Abandoned
- 2004-05-19 BR BRPI0410761-6A patent/BRPI0410761A/pt not_active Application Discontinuation
- 2004-05-19 WO PCT/NL2004/000355 patent/WO2004103383A1/en not_active Ceased
- 2004-05-19 EP EP04748592A patent/EP1633377B1/de not_active Revoked
- 2004-05-19 AT AT04748592T patent/ATE357241T1/de active
- 2004-05-19 ES ES04748592T patent/ES2282880T3/es not_active Expired - Lifetime
- 2004-05-19 JP JP2006532129A patent/JP2007500208A/ja active Pending
- 2004-05-19 DE DE602004005455T patent/DE602004005455T2/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
BRPI0410761A (pt)	2006-06-27
CN1809367A (zh)	2006-07-26
DE602004005455T2 (de)	2007-11-29
CN100448453C (zh)	2009-01-07
AU2004241884B2 (en)	2009-07-30
AU2004241884A1 (en)	2004-12-02
CA2526349A1 (en)	2004-12-02
US20070042019A1 (en)	2007-02-22
JP2007500208A (ja)	2007-01-11
ES2282880T3 (es)	2007-10-16
WO2004103383A1 (en)	2004-12-02
EP1633377A1 (de)	2006-03-15
AU2004241884A2 (en)	2004-12-02
EP1633377B1 (de)	2007-03-21
DE602004005455D1 (de)	2007-05-03

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1633377

Country of ref document: EP

Publication	Publication Date	Title
WO2004103294A3 (en)	2005-05-26	Methods and compositions for the prevention and treatment of sepsis
ATE326239T1 (de)	2006-06-15	Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren
DE502007002101D1 (de)	2010-01-07	Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
BR0313282A (pt)	2005-10-18	Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
SI2298338T1 (sl)	2012-11-30	Laktoferinski sestavki in postopki za zdravljenjekožnih ran
ATE235825T1 (de)	2003-04-15	Mehrzweck zusammensetzungen von säuren
BG102619A (en)	1999-04-30	Substituted n-[(aminoiminomethyl or aminomethyl) phenyl] propylamides
BR0214772A (pt)	2007-01-09	sistemas e métodos para o tratamento de pacientes com células lipoaspiradas processadas
ATE399553T1 (de)	2008-07-15	Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
TW200509956A (en)	2005-03-16	Compositions and methods for treatment of rosacea
DE602004005455D1 (de)	2007-05-03	Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
DE602004031134D1 (de)	2011-03-03	Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
WO2004103297A3 (en)	2005-03-17	Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis
DE60327557D1 (de)	2009-06-18	Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
CY1108138T1 (el)	2014-02-12	Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
NO20060498L (no)	2006-02-24	Metode for a promotere benvekst
ATE271873T1 (de)	2004-08-15	Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE50207740D1 (de)	2006-09-14	Verwendung von phosphatidylserin zur behandlung des aufmerksamkeits-defizit-syndroms (adhs)
MXPA04000428A (es)	2004-03-18	Alimento que contiene proteina que comprende una enzima de entrelazamiento y un hidrocoloide.
DE69902520D1 (de)	2002-09-19	Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
WO2004058268A3 (de)	2004-09-30	Verwendung von tetrahydrobiopterinderivaten zur behandlung und ernährung von patienten mit aminosäurestoffwechselstörungen
WO2005116233A3 (en)	2006-10-05	Composition and method of cancer treatment
EA200800397A1 (ru)	2008-08-29	Композиции тизанидина и способы лечения с применением композиций
ATE359808T1 (de)	2007-05-15	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60229240D1 (de)	2008-11-20	Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes